394 related articles for article (PubMed ID: 25777983)
1. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
Warlé-van Herwaarden MF; Koffeman AR; Valkhoff VE; 't Jong GW; Kramers C; Sturkenboom MC; De Smet PA
Br J Clin Pharmacol; 2015 Sep; 80(3):589-98. PubMed ID: 25777983
[TBL] [Abstract][Full Text] [Related]
2. Prescription audit of NSAIDs and gastroprotective strategy in elderly in primary care.
Al Khaja KAJ; Veeramuthu S; Isa HA; Sequeira RP
Int J Risk Saf Med; 2017; 29(1-2):57-68. PubMed ID: 28885223
[TBL] [Abstract][Full Text] [Related]
3. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study.
Ho CW; Tse YK; Wu B; Mulder CJ; Chan FK
Aliment Pharmacol Ther; 2013 Apr; 37(8):819-24. PubMed ID: 23432193
[TBL] [Abstract][Full Text] [Related]
4. Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries.
Fujita T; Kutsumi H; Sanuki T; Hayakumo T; Azuma T
J Gastroenterol; 2013 May; 48(5):559-73. PubMed ID: 23460386
[TBL] [Abstract][Full Text] [Related]
5. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
6. Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study.
Valkhoff VE; van Soest EM; Masclee GM; de Bie S; Mazzaglia G; Molokhia M; Kuipers EJ; Sturkenboom MC
Aliment Pharmacol Ther; 2012 Oct; 36(8):790-9. PubMed ID: 22928490
[TBL] [Abstract][Full Text] [Related]
7. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Niro V; Longo MG; D'Ambrosio LP; Andriulli A; Di Mario F
Aging Clin Exp Res; 2003 Dec; 15(6):494-9. PubMed ID: 14959953
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.
Johnell K; Fastbom J
Clin Drug Investig; 2008; 28(11):687-95. PubMed ID: 18840011
[TBL] [Abstract][Full Text] [Related]
9. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
[TBL] [Abstract][Full Text] [Related]
10. Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients.
Lanas A; Polo-Tomás M; Roncales P; Gonzalez MA; Zapardiel J
Am J Gastroenterol; 2012 May; 107(5):707-14. PubMed ID: 22334248
[TBL] [Abstract][Full Text] [Related]
11. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs.
Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users.
Teichert M; Griens F; Buijs E; Wensing M; De Smet PA
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):382-9. PubMed ID: 24535837
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor treatment decreases the incidence of upper gastrointestinal disorders in elderly Japanese patients treated with NSAIDs.
Sakamoto Y; Shimoyama T; Nakagawa S; Mikami T; Fukuda S
Intern Med; 2014; 53(11):1107-11. PubMed ID: 24881732
[TBL] [Abstract][Full Text] [Related]
14. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
[TBL] [Abstract][Full Text] [Related]
15. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
16. Gastroprotection in NSAID and low-dose aspirin users: a cross-sectional study in primary care.
Lanas A; Plazas MA; Gimeno E; Muñoz-Tudurí M
Gastroenterol Hepatol; 2012 Jan; 35(1):1-7. PubMed ID: 22178503
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole.
Lanas A; Rodrigo L; Márquez JL; Bajador E; Pérez-Roldan F; Cabrol J; Quintero E; Montoro M; Gomollón F; Santolaria S; Lorente S; Cucala M; Nuevo J;
Scand J Gastroenterol; 2003 Jul; 38(7):693-700. PubMed ID: 12889553
[TBL] [Abstract][Full Text] [Related]
18. Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptions.
Pasina L; Nobili A; Tettamanti M; Riva E; Lucca U; Piccinelli R; Defendi L; Perego L; Lucifora S; Bulla C
Int J Clin Pharmacol Ther; 2010 Nov; 48(11):735-43. PubMed ID: 20979932
[TBL] [Abstract][Full Text] [Related]
19. The rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an H2-receptor antagonist in Nova Scotia seniors starting nonsteroidal anti-inflammatory drug therapy.
Superceanu B; Veldhuyzen van Zanten S; Skedgel C; Shepherd M; Sketris I
Can J Gastroenterol; 2010 Aug; 24(8):481-8. PubMed ID: 20711527
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
